Correlation between serum IL 37 levels with keloid severity

FM Khattab, MA Samir - Journal of Cosmetic Dermatology, 2020 - Wiley Online Library
FM Khattab, MA Samir
Journal of Cosmetic Dermatology, 2020Wiley Online Library
Background Keloids are dermal fibroproliferative disorders that characterized by over
deposition of components of the extracellular matrix. Interleukin 37 (IL‐37) is known by its
ability to inhibit the proliferation of keloid fibroblasts by inhibiting extracellular matrix
production induced by transforming growth factor β (TGF‐β). Thus, Il‐37 is suggested to be
used as an early preventive treatment for keloids. Aims This study aimed to evaluate the
correlation between serum levels of IL37 level and the keloid severity. Patients/Methods This …
Background
Keloids are dermal fibroproliferative disorders that characterized by over deposition of components of the extracellular matrix. Interleukin 37 (IL‐37) is known by its ability to inhibit the proliferation of keloid fibroblasts by inhibiting extracellular matrix production induced by transforming growth factor β (TGF‐β). Thus, Il‐37 is suggested to be used as an early preventive treatment for keloids.
Aims
This study aimed to evaluate the correlation between serum levels of IL37 level and the keloid severity.
Patients/Methods
This is a cross‐sectional analytic study involving thirty‐two patients diagnosed clinically as having Keloid. An assessment of keloid severity was conducted by using Vancouver Scar Scale (VSS). Blood samples were collected from every patient to measure and assess the serum levels of IL37.
Results
A negative correlation was found between IL37 level and the keloid severity (P = .0001; r = −.737). Also, there was a nonsignificant correlation between IL37 levels in patient with keloid and age, gender, duration of lesions, and family history.
Conclusion
Lower level of plasma IL 37 could be an indicator of the severity of Keloids.
Wiley Online Library